Back
EAPC Premium Access

Design of the FRAIL-AF study: safety of switching anticoagulant management (from VKA to NOAC) in frail elderly patients with atrial fibrillation: a randomised controlled trial

Session: Poster Session 1 - Arrhythmias and device therapy
Topic: Atrial Fibrillation, Other
Speaker: Ms L. Joosten (Utrecht, NL)
Event: EuroPrevent 2018

Congress Presentation

About the speaker

Ms Linda Joosten

Julius Center for Health Sciences and Primary Care, Utrecht (Netherlands (The))
2 presentations
1 follower

5 more presentations in this session

Arrhythmias and device therapy - Poster discussant:

Access
Thumbnail

Anticoagulant therapy in patients with atrial fibrillation and diabetic or non-diabetic chronic kidney disease

Speaker: Doctor I. Daaboul (Moscow, RU)

Access
Abstract
Slides
Thumbnail

The quality of life in patients with paroxysmal atrial fibrillation after catheter ablation

Speaker: Professor N. Pogosova (Moscow, RU)

Access
Abstract
Thumbnail

De novo atrial arrhythmia after isolated surgical aortic valve replacement

Speaker: Assistant Professor Y. Hwang (Suwon, KP)

Access
Abstract
Thumbnail

Failure to anticoagulate patients with Atrial Fibrillation despite a high CHA2DS2Vasc score

Speaker: Miss Y. Bashir (London, GB)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 1 - Arrhythmias and device therapy

Speakers: Ms L. Joosten, Doctor I. Daaboul, Professor N. Pogosova, Assistant Professor Y. Hwang, Miss Y. Bashir
Access
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb